SCHEMBL65902

SCHEMBL65902

O=C(CC(c1ccccc1)c1ccccc1)NC1CCC2CN(Cc3cccc(C(F)(F)F)c3)CC21

nearest known ligand 0.67

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CACNA1B Q00975 5/20 0.67
KCNH2 Q12809 2/20 0.67
SIGMAR1 Q99720 2/20 0.52
SCN9A Q15858 2/20 0.47
BCHE P06276 1/20 0.46
FAAH O00519 1/20 0.46
BACE1 P56817 1/20 0.46
S1PR1 P21453 1/20 0.46
GRK5 P34947 1/20 0.46
CDK8 P49336 1/20 0.46
S1PR5 Q9H228 1/20 0.46
FFAR1 O14842 1/20 0.45
UBE2M P61081 1/20 0.45
DCUN1D1 Q96GG9 1/20 0.45
TACR1 P25103 1/20 0.44
CCR2 P41597 1/20 0.44
DRD4 P21917 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL66306 1.00 CACNA1B (0.67) CACNA1BKCNH2SIGMAR1SCN9ABCHE
SCHEMBL65903 1.00 CACNA1B (0.67) CACNA1BKCNH2SIGMAR1SCN9ABCHE
SCHEMBL66527 0.94 CACNA1B (0.64) CACNA1BKCNH2SIGMAR1SCN9AFAAH
SCHEMBL66080 0.94 CACNA1B (0.64) CACNA1BKCNH2SIGMAR1SCN9AFAAH
SCHEMBL66081 0.94 CACNA1B (0.64) CACNA1BKCNH2SIGMAR1SCN9AFAAH
SCHEMBL65849 0.88 CACNA1B (0.73) CACNA1BKCNH2SIGMAR1SCN9ABCHE
SCHEMBL65959 0.88 CACNA1B (0.73) CACNA1BKCNH2SIGMAR1SCN9ABCHE
SCHEMBL65850 0.88 CACNA1B (0.73) CACNA1BKCNH2SIGMAR1SCN9ABCHE
SCHEMBL66363 0.87 CACNA1B (0.66) CACNA1BKCNH2SIGMAR1SCN9AFAAH
SCHEMBL65731 0.87 CACNA1B (0.66) CACNA1BKCNH2SIGMAR1SCN9AFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8129417-B2 Substituted octahydrocyclopenta[C]pyrrol-4-amines as calcium channel blockers ABBOTT LABORATORIES (US) 2012-03-06 US claimed
US-20110281870-A1 NOVEL SUBSTITUTED OCTAHYDROCYCLOPENTA[C]PYRROL-4-AMINES AS CALCIUM CHANNEL BLOCKERS ABBOTT LABORATORIES (US) 2011-11-17 US claimed
US-20100130558-A1 NOVEL SUBSTITUTED OCTAHYDROCYCLOPENTA[C]PYRROL-4-AMINES AS CALCIUM CHANNEL BLOCKERS ABBOTT LABORATORIES (US) 2010-05-27 US claimed
US-8129417-B2 Substituted octahydrocyclopenta[C]pyrrol-4-amines as calcium channel blockers ABBOTT LABORATORIES (US) 2012-03-06 US disclosed
US-20110281870-A1 NOVEL SUBSTITUTED OCTAHYDROCYCLOPENTA[C]PYRROL-4-AMINES AS CALCIUM CHANNEL BLOCKERS ABBOTT LABORATORIES (US) 2011-11-17 US disclosed
US-20100130558-A1 NOVEL SUBSTITUTED OCTAHYDROCYCLOPENTA[C]PYRROL-4-AMINES AS CALCIUM CHANNEL BLOCKERS ABBOTT LABORATORIES (US) 2010-05-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100130558-A1 NOVEL SUBSTITUTED OCTAHYDROCYCLOPENTA[C]PYRROL-4-AMINES AS CALCIUM CHANNEL BLOCKERS CACNA1C, ORAI1, CACNA1S CACNA1B 5/4885KCNH2 24/4885SIGMAR1 576/4885
US-20110281870-A1 NOVEL SUBSTITUTED OCTAHYDROCYCLOPENTA[C]PYRROL-4-AMINES AS CALCIUM CHANNEL BLOCKERS CACNA1C, ORAI1, CACNA1S CACNA1B 5/4885KCNH2 24/4885SIGMAR1 576/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.